Log In
BCIQ
Print this Print this
 

XD160-TX

  Manage Alerts
Collapse Summary General Information
Company BioCydex S.A.S.
DescriptionDocetaxel formulation with Solvamax technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today